Suppr超能文献

62例鼻型NK/T细胞淋巴瘤的预后分析

[Prognostic analysis of 62 cases of nasal NK/T-cell lymphoma].

作者信息

Xiao Jian, Wang Shu-Sen, Huang Yan, Chen Li-Kun, Guan Zhong-Zhen, Huang Hui-Qiang, Xia Zhong-Jun, Xu Rui-Hua, Lin Tong-Yu

机构信息

State Key Laboratory of Oncology in South China, Guangzhou, Guangdong, 510060, P. R. China.

出版信息

Ai Zheng. 2006 Sep;25(9):1173-7.

Abstract

BACKGROUND & OBJECTIVE: Extranodal NK/T-cell lymphoma of nasal type (ENKTL) is a rare disease entity with unique biological behavior, of which definitive characteristics are still unknown. This study was to investigate the clinical features and prognostic factors of ENKTL in the population of southern China.

METHODS

Records of 62 patients with pathologically confirmed ENKTL, treated in Cancer Center of Sun Yat-sen University from Jan. 1999 to Dec. 2004, were reviewed. Detailed clinical and laboratory data were included in univariate analysis, and statistically significant factors in univariate analysis were then included in multivariate analysis.

RESULTS

Of the 62 patients, 47 were men, and 15 were women, with the median age of 42; 92% of the patients had localized disease, and 76% had international prognostic index (IPI) of 0 or 1. Before treatment, 26% of the patients had anemia, 92% had ECOG performance status (PS) score of 0-1, and 53% presented B symptoms. With a median follow-up duration of 18 months, the median overall survival time was 27 months (95% CI: 10-45 months). In multivariate analysis, hemoglobin (Hb) <110 g/L, B symptoms, and ECOG PS score >1 were statistically significant unfavorable prognostic factors.

CONCLUSION

Hb together with B symptoms and PS score may be independent prognostic factors for ENKTL.

摘要

背景与目的

鼻型结外NK/T细胞淋巴瘤(ENKTL)是一种具有独特生物学行为的罕见疾病实体,其确切特征仍不清楚。本研究旨在探讨中国南方人群中ENKTL的临床特征及预后因素。

方法

回顾性分析1999年1月至2004年12月在中山大学肿瘤防治中心接受治疗的62例经病理确诊的ENKTL患者的病历资料。详细的临床和实验室数据纳入单因素分析,单因素分析中有统计学意义的因素再纳入多因素分析。

结果

62例患者中,男性47例,女性15例,中位年龄42岁;92%的患者为局限性病变,76%的患者国际预后指数(IPI)为0或1。治疗前,26%的患者有贫血,92%的患者东部肿瘤协作组(ECOG)体能状态(PS)评分为0 - 1,53%的患者有B症状。中位随访时间为18个月,中位总生存时间为27个月(95%CI:10 - 45个月)。多因素分析显示,血红蛋白(Hb)<110 g/L、B症状及ECOG PS评分>1是具有统计学意义的不良预后因素。

结论

Hb、B症状及PS评分可能是ENKTL的独立预后因素。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验